BioNTech’s updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus. The ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

A factor that has changed over time is hospitalization due to severe COVID infections. On Aug. 1, the statewide seven-day ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $12.8 which represents a decrease of $-0.11 or -0.85% from the prior close of $12.91. The stock opened at $13.01 and touched a low ...

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

The US government plans to make more at-home Covid-19 tests available for free this month as the country heads into ...

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 ...